- Home
- RAPT vs CBLL Comparison
RAPT vs CBLL Comparison
Compare RAPT & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CBLL
- Stock Information
- Founded
- RAPT 2015
- CBLL 2014
- Country
- RAPT United States
- CBLL United States
- Employees
- RAPT N/A
- CBLL N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CBLL
- Sector
- RAPT Health Care
- CBLL
- Exchange
- RAPT Nasdaq
- CBLL Nasdaq
- Market Cap
- RAPT 498.4M
- CBLL 433.7M
- IPO Year
- RAPT 2019
- CBLL 2024
- Fundamental
- Price
- RAPT $29.86
- CBLL $13.21
- Analyst Decision
- RAPT Strong Buy
- CBLL Strong Buy
- Analyst Count
- RAPT 8
- CBLL 7
- Target Price
- RAPT $46.75
- CBLL $30.67
- AVG Volume (30 Days)
- RAPT 614.9K
- CBLL 245.3K
- Earning Date
- RAPT 11-11-2025
- CBLL 11-04-2025
- Dividend Yield
- RAPT N/A
- CBLL N/A
- EPS Growth
- RAPT N/A
- CBLL N/A
- EPS
- RAPT N/A
- CBLL N/A
- Revenue
- RAPT N/A
- CBLL $77,419,000.00
- Revenue This Year
- RAPT N/A
- CBLL $35.46
- Revenue Next Year
- RAPT N/A
- CBLL $28.18
- P/E Ratio
- RAPT N/A
- CBLL N/A
- Revenue Growth
- RAPT N/A
- CBLL 42.16
- 52 Week Low
- RAPT $5.67
- CBLL $10.01
- 52 Week High
- RAPT $42.39
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- RAPT 61.81
- CBLL 57.93
- Support Level
- RAPT $25.50
- CBLL $12.33
- Resistance Level
- RAPT $42.39
- CBLL $12.94
- Average True Range (ATR)
- RAPT 3.91
- CBLL 0.69
- MACD
- RAPT -0.18
- CBLL 0.14
- Stochastic Oscillator
- RAPT 30.92
- CBLL 71.66
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.